Clinical AI Advantage Qmetrics offers AI-driven medical image analysis and biomarker development capabilities that can enhance clinical trial endpoints, improve therapeutic efficacy assessments, and enable more precise disease progression tracking for imaging-centric programs.

FDA Cleared Edge Their Kuvia3D product is FDA cleared for 3D visualization of joint anatomy from DICOM data, presenting a compliant, revenue-ready tool that can be upsold to surgical planning, non-surgical therapy, and perioperative decision support customers.

Global Service Model Despite a small team, Qmetrics provides international services, indicating potential for scalable collaboration with larger imaging centers, research networks, and contract research organizations seeking advanced image analytics.

Cost Efficiency Pitch Automated image processing and AI-driven data extraction position Qmetrics as a way for clients to reduce trial costs and accelerate timelines through objective, quantitative imaging biomarkers.

Startup Scale Opportunities With revenue in the sub‑$10M range and a lean 2–10 employee base, there is room to expand through partnerships, channel deals with imaging hardware/software vendors, and targeted outreach to mid‑market hospitals and imaging centers seeking advanced analytics.